Table 5. Serum levels of IGF1 according to the clinical characteristics of HCC patients.
| Factor and subset | n | Mean ± SD | p value | Relative mean and SD |
|---|---|---|---|---|
| Age (years) |  |
|||
| < 60 | 333 | 99.42 ± 58.50 | 0.584 | |
| ≥ 60 | 195 | 96.23 ± 73.59 | ||
| Gender | ||||
| Female | 140 | 90.24 ± 53.50 | 0.4 | |
| Male | 323 | 85.76 ± 52.08 | ||
| Hepatitis infection status | ||||
| None | 36 | 101.58 ± 84.73 | 0.962 | |
| HBV | 337 | 102.18 ± 70.57 | 0.034 | |
| HCV | 57 | 81.25 ± 56.69 | ||
| Child-Pugh class | ||||
| A | 336 | 109.12 ± 76.76 | 0.653 | |
| B | 137 | 112.94 ± 98.14 | 0.002 | |
| C | 79 | 158.75 ± 117.3 | ||
| Serum AFP level(ng/ml) | ||||
| < 200 | 264 | 87.45 ± 54.46 | 0.353 | |
| ≥ 200 | 120 | 93.23 ± 60.58 | ||
| Tumor nodularity | ||||
| Monofocal disease | 155 | 76.19 ± 54.02 | 0.98 | |
| Multifocal | 113 | 76.34 ± 42.77 | ||
| BCLC stage | ||||
| 0 | 45 | 100.56 ± 64.74 | 0.376 | |
| A | 163 | 109.73 ± 60.53 | < 0.001 | |
| B | 136 | 72.34 ± 46.13 | 0.019 | |
| C | 99 | 86.29 ± 43.05 | ||
| Vascular invasion | ||||
| No | 147 | 80.21 ± 57.86 | 0.166 | |
| Yes | 70 | 90.62 ± 34.48 | ||